A Role of PET and CT Examinations in the Management of Malignant Disorders of the Large Intestine and Rectum – A Review
Authors:
M. Ondrák; R. Šefr
Authors place of work:
Oddělení onkologické chirurgie, Masarykův onkologický ústav Brno, primář: MUDr. V. Chrenko, CSc.
Published in the journal:
Rozhl. Chir., 2007, roč. 86, č. 9, s. 461-465.
Category:
Monothematic special - Original
Summary
Current treatment methods of solid malignant disorders, in particular, depend, more and more, on perfection of paraclinical examination methods. Clinical examination conclusions, supported by imaging findings, determine the treatment strategy. Radical surgical procedures still remain the only treatment modality resulting in a patient’s recovery. Correct timing of the procedure with respect to other therapeutical modalities, has a major positive impact on the treatment success rates. Ongoing improvements of imaging methods and development of new methods introduced in our clinical practice have made individual patient treatment plans possible.
The overview includes brief history of the imaging techniques development, as well as current situation in the large intestinal and rectal malignancies in various disease stages, supported by the most significant of the few presented studies.
Key words:
positron emission tomography – computer tomography – colorectal carcinoma
Zdroje
1. Abdel-Nabi, H., Doerr, R J., Lamonica, D M. Staging of Primary Colorectal Carcinomas with Fluorine-18 Fluorodeoxyglucose Whole-Body PET: Correlation with Histopathologic and CT Findings. Radiology, 1998, roč. 206, č. 3., s. 755–760.
2. Abdel-Nabi, H., Lamonica, D., Spaulding, M., et al. Localization of occult/recurrent colorectal cancers with F – 18 FDG whole body PET: comparison with conventional diagnostic modalities. J. Nucl. Med., 1995, roč. 36, s. 106P.
3. Boren, E. R. Jr., Delbeke, D., Patton, J. A., et al. Comparison of FDG PET and positron coincidence imaging using a dual-head gamma camera with 5/8-inch NaI(TI)crystals in patients with suspected body malignanies. Eur. J. Nucl. Med., 1999, roč. 26, č. 4, s. 379–387.
4. Capirci, C., Rubello, D., Chierichetti, F., et al. Restaging after neoadjuvant chemoradiotherapyfor rectal adenocarcinoma: role of F18 – FDG PET. Biomedicine and Pharmacotherapy, 2004, roč. 58, s. 451–457
5. Carron, M., Beyer, T., Bohnen, N. N., er al. Image analysis in patients with cancer studied with a combined PET and CT scanner. Clin. Nucl. Med., 2000, roč. 25, s. 905–910.
6. Costa, D. C., Visvikis, D., Crosdale, I., et al. Positron emission and computed x-ray tomography:a coming together. Nucl. Med. Common., 2003, roč. 24, s. 351–358.
7. Delbeke, D., Vitola, J. V., Martin M. P., et al. Staging recurrent metastatic colorectal carcinoma with PET. J. Nucl. Med., 1997, roč. 38, č. 8, s. 1196–1201.
8. Diezendorf, E. V., Treyer, V., von Schulthess, G. K., et al. Application of oral contrast media in coregistered positron emission tomography-CT. AJR, 2002, roč. 179, s. 477–481.
9. Even-Sapir, E., Lerman, H., Figer, A., et al. Role of 18F-FDG Dual-Head Gamma-Camera Coincidnece Imaging in Recurrent of Metastatic Colorectal Carcinoma. The Journal of Nuclear Medicine, 2002, roč. 43, č. 5, s. 603–609.
10. Flamen, P., Stroobants, S., Cutsen, E. V., et al. Additional value of whole-body positron emission tomography with fluorine – 2 – fluoro – 2 – deoxy – D – glucose in recurrent colorectal cancer. J. Clin. Oncol., 1999, roč. 17, č. 3, s. 894–901.
11. Gordon, B. A., Flanagan, F. L., Dehdashti, F. Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations. Am. J. Roentgenol., 1997, roč. 169, s. 1675–1680.
12. Hoffman, E. J., Huang, S. C., Phelps, M. E. Quantitation in positron emission computed tomography. 1. effect of object size. J. Comput. Ässist. Tomogr., 1979, roč. 3, s. 299–308.
13. Chin, B. B., Wahl, R. L. 18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies. Gut, 2003, roč. 52, s. 23 – 29.
14. Imaginis – Milestones in Medical Diagnosis and Diagnostic Imaging [on line]. c1997 [cit. 2007-03-15]. Dostupný na www: http://imaginis.com/faq/milestones.asp?mode=1.
15. Kamel, E. M., Thumshirn, M., Truninger, K., et al. Significance of Inscidental 18F-FDG Accumulations in the Gastrointestinal Tract in PET/CT: Correlation with Endoscopic and Histopathologic Results. The Journal of Nuclear Medicine, 2004, roč. 45, č. 11, s.1804–1810.
16. Kantorová, I., Lipská, L., Bělohlávek, O., at al. Routine 18F-FDG PET Preoperative Staging of Colorectal Cancer: Comparison with Conventional Staging and IS Impact on Treatment Decision Making. The Journal of Nuclear Medicine, 2003, roč. 44, č. 11, s. 1784–1788.
17. Kinahan, P. E., Townsend, D. W., Beyer, T., Sashin, D. Atte-nuation correction of a combined 3D PET/CT scanner. Med Phys, 1998, roč. 25, s. 2046–2053.
18. Kluetz, P.,, Villemagne, V. V., Meltzer, C., et al. The case for PET/CT: experience at the University of Pittsburgh. Clin. Positron. Imaging, 2000, roč. 3, s. 174.
19. Kluetz, P. G., Meltzer, C. C., Villemanagne, V. L., et al. Combined PET/CT imaging in oncology: impact on patient management. Clin. Positro Imaging, 200, roč. 3, s. 223–230.
20. Kostadoglu, L., Hardoff, R., Mirtcheva, R., et al. PET-CT Fusion Imaging in Differentiating Physiologic from Pathologie FDG Uptake. RadioGraphics, 2004, roč. 24, č. 5, s. 1411–1431.
21. Kostakoglu, L., Agress, H., Goldsmith, J. S. Clinical role of FDG PET in evaluation of cancer patients. RadioGraphics, 2003, roč. 23, s. 315–339.
22. Lamki, L. M. Positron emission tomography in oncology: general acceptance of its role is overdue. Cancer, 1996, roč. 78, s. 2039–2042.
23. Mukai, M., Sadahiro, S., Yasuda, S., et al. Preoperative evaluation by whole-body 18F-fluorodeoxyglucose positron emission tomography in patients with primary colorectal cancer. Oncol. Rep., 2000, roč. 7, s. 84–87.
24. Ogunbiyi, O. A., Flanagan, F. L., Dehdashti, F., et al. Detection of recurrent and metastatic colorectal cancer: comparision of positron emission tomography and computed tomography. Ann. Surg. Oncol., 1997, roč. 4, s. 613–620.
25. Pounds, T. R., Valk, P. E., Haseman, M. K., et al. Whole body PET-FDG imaging in the diagnosis of recurrent colorectal cancer. J. Nucl. Med., 1995, roč. 36, s. 57P.
26. Reske, S. N., Kotzerke, J. FDG – PET for clinical use. Eur. J. Nucl. Med., 2001, roč. 28, č. 11 , s. 1707–1723.
27. Rio, P., Paulus, P., Kastchen, B. J., et al. Oncology applications of positron emission tomography with fluorine – 18 fluorodeoxyglucose. Eur. J. Nucl. Med., 1996, roč. 3, s. 1641–1674.
28. Scott, A. M., Macapinlac, H., Zhang. J. J., et al. Clinical Applications of Fusion Imaging in Oncology. Nucl. Med. Biol., 1994, roč. 21, č. 5, s. 775–784.
29. Shreve, P. D., Steventon, R. S., Deters, E. C., et al. Oncologic diagnosis with 2 – [fluorine – 18]fluoro – 2 – deoxy – D – glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner. Radiology, 1998, roč. 207, s. 431–437.
30. Schaffler, G. J., Groell, R., Schoellnast, H., et al. Digital Image Fusion of CT and PET Data Sets – Clinical Value in Abdominal/Pelvic Malignancies. Journal of Computer Assisted Tomography, 2000, roč. 24, č. 4, s. 644–647.
31. Stelzner, F., Ruhlmann, J. PET studies of recurrent rectal carcinoma. Fundamental aspects of lymphatic metastasis of visceral and somatics carcinomas. Chirurg, 2001, roč. 72, č. 5, s. 537–546.
32. Strauss, L. G., Clorius, B. M., Schlag, P., et al. Recurence of colorectal tumors: PET evaluation. Radilology, 1989, roč. 170, s. 329 – 332.
33. Tucker, R., Coel, M., Mprris, P., et al. Impact of fluorine – 18 fluorodeoxyglucose positron emission tomogrpahy on patient management: first year’s experience in a clinical center. J. Clin. Oncol., 2001, roč. 19, č. 9, s. 2504–2058.
34. Wahl, R. L. Targeting glucosa transporters for tumor imaging: „sweet“ idea, „sour“ results. J. Nucl. Med., 1996, roč. 37, č. 6, s. 1038–1041.
35. Whiteford, M. H., Yee, L. F., et al. Usefulness of FDG – PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis. Colon Rectum, 2000, roč. 43, s. 759–770.
36. Zasadny, K. R., Kison, P. V., Francis, I. R., et al. FDG-PET determination of metabolically active tumor volume and comparison with CT. Clinical Positron Imaging, 1998, roč. 1, č. 2, s. 123–129.
Štítky
Anaesthesiology, Resuscitation and Inten Paediatric surgery Paediatric urologist Vascular surgery Chest surgery Maxillofacial surgery Plastic surgery Surgery Intensive Care Medicine Cardiac surgery Cardiology Neurosurgery Clinical oncology Orthopaedics Burns medicine Orthopaedic prosthetics Rehabilitation Nurse Traumatology Trauma surgery Urology Medical studentČlánok vyšiel v časopise
Perspectives in Surgery
2007 Číslo 9
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole vs. Tramadol in Postoperative Analgesia
- Advances in the Treatment of Myasthenia Gravis on the Horizon
Najčítanejšie v tomto čísle
- Symptomatic Meckel’s Diverticulum in Children
- Indirect Antireflux Procedures in Gastroesophageal Reflux Disorders
- Occlusive Ileus Caused by Intestinal Duplication
- Preliminary Experience in Minimally Invasive Video Assissted Parathyroidectomy